# Pneumococcal Vaccine Polyvalent

## Pneumovax 23 (Private) 0.5mL/dose

| TAH Drug Code      | [**IPNE**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPNE)                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine                                                                                                                                                                                                                                                 |
| Dosing             | IM or SC, 0.5mL, > or = 2 years a single dose.                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised < 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| Adverse Effects    | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia.                                                                                                                                                                                                                              |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                        |

## Pneumovax 23 (Government) 0.5mL/dose

| TAH Drug Code      | [**IPNE0**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPNE0)                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine                                                                                                                                                                                                                                                 |
| Dosing             | IM or SC, 0.5mL, > or = 2 years a single dose.                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised < 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| Adverse Effects    | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia.                                                                                                                                                                                                                              |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                        |

## Pneumovax 23 (Taipei City) 0.5mL/dose

| TAH Drug Code      | [**IPNE1**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPNE1)                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine                                                                                                                                                                                                                                                 |
| Dosing             | IM or SC, 0.5mL, > or = 2 years a single dose.                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity. Revaccination of adults with Pneumovax 23 is contraindicated except for those at highest risk of pneumococcal infections. Patients with Hodgkin's disease immunised < 7 to 10 days prior to or during immunosuppressive therapy & patients with Hodgkin's disease who have received extensive chemotherapy &/or nodal irradiation. |
| Adverse Effects    | Local inj-site soreness, warmth, erythema & swelling. Fever, headache, malaise, rash, urticaria, arthritis, arthralgia.                                                                                                                                                                                                                              |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                        |

## Prevenar 13 (Private) 0.5mL/dose

| TAH Drug Code      | [**IPR13**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPR13)                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation of infants & toddlers against invasive disease caused by Strep pneumoniae serotypes (4, 6B, 9V, 14, 18C, 19F & 23F) at 2, 4, 6 & 12-15 months of age. Active immunisation of infants & toddlers < 2 years against otitis media caused by Strep pneumoniae serotypes (1, 2, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F & 23F).     |
| Dosing             | IM, 0.5mL, children 2-6 months 3 doses primary immunization at intervals of 1 month (the 1st dose can be given at 6 weeks of age), a booster dose at 12-15 months. 7-11 months 2 doses primary immunization at an interval of 1 month , a booster dose at 12 months. 12-23 months 2 doses at intervals of 2 months. > or = 2 years a single dose. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Decreased appetite, vomiting, diarrhoea, injection site reactions (e.g. erythema, induration/swelling, pain/tenderness), tenderness interfering with movement, fever, irritability, drowsiness, restless sleep.                                                                                                                                   |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                     |

## Prevenar (政府提供,13價肺炎) 0.5mL/dose

| TAH Drug Code      | [**IPRE1**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPRE1)                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants and children from 2 month-5 years.                                                                                                                                     |
| Dosing             | IM, 0.5mL, children 2-6 months 3 doses primary immunization at intervals of 1 month (the 1st dose can be given at 6 weeks of age), a booster dose at 12-15 months. 7-11 months 2 doses primary immunization at intervals of 1 month , a booster dose at 12 months. 12-23 months 2 doses at intervals of 2 months. > or = 2 years a single dose. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Decreased appetite, irritability, drowsiness/increased sleep, restless sleep/decreased sleep, fever, inj site erythema, induration/swelling or pain/tenderness, rash.                                                                                                                                                                           |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                   |

